December 1, 2025 C-Path Rare/0rphan and Pediatric Disease Programs Q4 2025 Newsletter Now Available Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements, webinars...
November 24, 2025 C-Path Consortium Adds Gene Editing and Advanced Imaging Leaders to Accelerate Alpha-1 Research Beam Therapeutics and the Open Source Imaging Consortium join C-Path’s CPA-1 program, bringing gene editing innovation and...
November 20, 2025 C-Path Announces New Name and Strategic Direction for its PRO Consortium C-Path's PRO Consortium has adopted a new name, the Patient-Centered Evidence Consortium (PCEC), to reflect its...
November 19, 2025 FDA Qualifies C-Path Biomarker GLDH to Detect Liver Injury in Clinical Trials C-Path today announced that the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, through its..
November 18, 2025 C-Path’s International Neonatal Consortium Launches Groundbreaking Neonatal Lab Values GUI Tool to Standardize Reference Ranges in Neonatal Trials TUCSON, Ariz., November 18, 2025 — Critical Path Institute’s® (C-Path) International Neonatal Consortium (INC) today announce
November 11, 2025 In Memoriam: C-Path Remembers Dr. Gil L’Italien’s Legacy of Science, Compassion, and Collaboration Critical Path Institute is deeply saddened by the passing of Dr. Gilbert L’Italien, or Gil to those who knew him...
November 3, 2025 Celebrating a Decade of Impact: Critical Path for Parkinson’s 10-Year Impact Report Now Available Critical Path for Parkinson’s (CPP), a global public-private partnership led by C-Path...
October 16, 2025 C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub Critical Path Institute® (C-Path) today announced the official launch of the Critical Path Disease...
October 7, 2025 C-Path CEO Romero Featured in Scientific American Feature The piece explores the concept of healthspan — the years of life lived free from serious disease — a topic gaining momentum...